| Literature DB >> 35574432 |
Yuqing Zhao1,2, Yanxin An3, Libo Zhou4, Fan Wu2, Gaoyi Wu2, Jing Wang5,6, Lei Chen1.
Abstract
Temporomandibular joint osteoarthritis (TMJOA) is a common degenerative joint disease that can cause severe pain and dysfunction. It has a serious impact on the quality of lives of patients. Since mechanism underlying the pathogenesis of TMJOA is not fully understood, the development of effective tools for early diagnosis and disease-modifying therapies has been hindered. Animal models play a key role in understanding the pathological process of diseases and evaluating new therapeutic interventions. Although some similarities in disease processes between animals and humans are known, no one animal model is sufficient for studying all characteristics of TMJOA, as each model has different translatability to human clinical conditions. For the past 4 decades, TMJOA animal models have been studied by numerous researchers and can be broadly divided into induced, naturally occurring, and genetically modified models. The induced models can be divided into invasive models (intra-articular injection and surgical induction) or non-invasive models (mechanical loading, high-fat diet, and sleep deprivation). Different types of animal models simulate different pathological expressions of TMJOA and have their unique characteristics. Currently, mice, rats, and rabbits are commonly used in the study of TMJOA. This review sought to provide a general description of current experimental models of TMJOA and assist researchers in selecting the most appropriate models for different kinds of research.Entities:
Keywords: animal models; genetically modified models; induced models; naturally occurring models; osteoarthritis; temporomandibular joint
Year: 2022 PMID: 35574432 PMCID: PMC9095932 DOI: 10.3389/fphys.2022.859517
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1Common microstructural and histopathological alterations in cartilage and subchondral bone of TMJOA animal models with showing the normal joint and pathological joint. In normal joint, the surface of condylar cartilage is intact and smooth with four layers, including fibrous, proliferative, hypertrophic, and calcified cartilage layers. Lesions of cartilage include loss of cartilage surface integrity and proteoglycan, reduced and irregular arrangement of chondrocytes, presence of chondrocyte clusters and cell-free areas, decreased thickness of cartilage, apoptosis of chondrocytes and osteophyte formation. Subchondral bone appears as osteochondral angiogenesis, increased trabecular separation, large marrow cavities, decreased bone volume fraction, and activation of osteoblasts and osteoclasts.
FIGURE 2Classification of temporomandibular joint osteoarthritis (TMJOA) models. These models and their subdivisions share a relationship with TMJOA phenotypes. Black arrows indicate the classification based on whether the animals are treated with or without intervention. Dashed red box represents pathogenic factors simulated by each model. Blue lines indicate the specific animal species or model-building methods for each animal model.
Common TMJOA models and their basic characteristics.
| Model | Pros | Cons | Indications |
|---|---|---|---|
| Intra-articular injection models | Easy to operate | Pathogenic mechanism is different from human TMJOA | Mainly used for study of pain and inflammatory response |
| Small trauma | |||
| Dose-dependent effects | |||
| Surgical induction models | Induce TMJOA quickly | Risks of inflection | Mimic post-traumatic TMJOA |
| Severe lesions | May affect other part of the joint | ||
| Mechanical loading models | No trauma | Mild lesions | Mimic TMJOA caused by occlusal factors |
| Present little risk for animals | Complex process of model-building | ||
| Need specialized equipment | |||
| High-fat diet models | Easy to operate | Mild lesions | Mimic TMJOA affected by obesity factors |
| High repeatability | |||
| Sleep deprivation models | High repeatability | Sleep of rodent animals are naturally different from that of human | Mimic TMJOA under psychological stress |
| Naturally occurring models | No external interventions and induction required | Slow procession of disease | Mimic primary TMJOA |
| Extremely long research period | |||
| High cost | |||
| Genetically modified models | Develop disease naturally | Only act on specific genes | Study the function of a specific gene in TMJOA pathogenesis |
| Long research period | |||
| High cost |
Intra-articular injection models of TMJOA animal models.
| Drugs | Species | Changes of Condylar Cartilage | Changes in other parts of TMJ | Molecular Mechanisms |
|---|---|---|---|---|
| MIA | Rat ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ |
| CFA | Mouse ( | Cartilage defection | Subchondral bone degradation | ↑ RANKL, OCN, MMP-13, COL X, ADAMTS-5 in whole condyle; IHH, PTCH1 in hypertrophic layer; SMO, GLI1 in hypertrophic and mineralized layer |
| Collagenase | Mouse ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ |
| Papain | Rabbit ( | Cartilage matrix degradation | Articular disc degradation | — |
| VEGF | Mouse ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ MMP-9 and MMP-13 in hypertrophic layer; VEGFR2 in all cartilage layers; RANKL in subchondral bone |
Surgical induction models of TMJOA animal models.
| Surgical Induction Models | Species | Changes of Condylar Cartilage | Changes in other parts of TMJ | Molecular Mechanisms |
|---|---|---|---|---|
| Discectomy | Mouse ( | Cartilage defection | Subchondral bone degradation | ↑ NOTCH1, HES5, TLR4, IL-1 β, TNF-α, ADAMTS-5, MMP-13 in cartilage; JAGGED-1 in chondrocyte clusters; NFκB P65, MyD88 in fibrous layer |
| Partial discectomy | Mouse ( | Cartilage defection | Subchondral bone degradation | ↑ DDR-2, MMP-13 in fibrous layer; IFN-γ, pSTAT4 in condylar cartilage |
| Disc perforation | Rat ( | Cartilage defection | Articular disc hyperplasia | ↑ RUNX2, BSP in hypertrophic layer; CD31, α-SMA in cartilage |
| Anterior disc displacement | Rat ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ ADAMTS-5 in hypertrophic layer; CHOP, CASPASE-3, GRP78, |
| Injury of condylar surface | Sheep ( | Cartilage matrix degradation | Subchondral bone degradation | — |
| Postero-superior displacement of mandible | Rabbit ( | Cartilage defection | Subchondral bone degradation | — |
Mechanical loading models of TMJOA animal models.
| Mechanical loading models | Species | Changes of Condylar Cartilage | Changes in other parts of TMJ | Molecular Mechanisms |
|---|---|---|---|---|
| Orthodontic tooth movement | Rat ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ CTXs in serum; RUNX-2, VEGF, CTGF, MMP-9, CHM-1, M-CSF, RANKL/OPG in hypertrophic layer; BECLIN-1, LC3-II in whole condyle |
| Unilateral anterior crossbite | Mouse ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ GRP78, CHOP, CASPASE-12, cleaved-CASPASE-3, |
| Unilateral bite-raise | Mouse ( | Fibrillation | Subchondral bone degradation | ↑ IL-6, TH in hypertrophic layer; IHH, SMO, MMP-13, CASPASE-3 in proliferative and hypertrophic layers; GLI-1 in cartilage |
| Mandibular movement restriction | Rat ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ BRDU in proliferative layer; Op, PDI, CRT, CHOP, CASPASE-3, BIP, p-EIF2α in cartilage |
| Mandibular advancement | Rat ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ MMP-13, CXCR4, SDF-1 in hypertrophic layer; RUNX2 in cartilage; OSX, p-S6 in subchondral bone |
| Mandibular lateral deviation | Rat ( | Cartilage defection | Subchondral bone degradation | ↑ |
| Impact loading | Goat ( | Cartilage defection | Exposure of subchondral bone | ↑ MMP-3 in cartilage; TIMP-1 in hypertrophic layer and synovial membrane |
| Forced-jaw-opening | Mouse ( | Fibrillation | Exposure of subchondral bone | ↑ MMP-1, MMP-3, MMP-9, MMP-13, IL-1β, |
| Soft diet | Mouse ( | Cartilage matrix degradation | Subchondral bone degradation | ↑ MMP-3, MMP-13 in whole condyle; |
Naturally occurring models of TMJOA animal models.
| Strain of animals | Age of Onset | Changes of Condylar Cartilage | Changes in other parts of TMJ | Molecular Mechanisms |
|---|---|---|---|---|
| STR/Ort mice ( | 40-week-old | Cartilage defection | Subchondral bone degradation | ↑ MMP-12 in cartilage; IL-6, ADAMTS-4, ADAMTS-5 in subchondral bone |
| STR/IN mice ( | 36-week-old | Cartilage defection | Glenoid fossa degradation | — |
| SAMP8 mice ( | 16-week-old | Cartilage matrix degradation | — | ↓ |
| C57BL/6S mice ( | 12-week-old | Cartilage defection | Subchondral bone degradation | ↑ CL-peptidase, PEP in serum |
| C57BL/6J mice ( | 45-week-old | Cartilage defection | Subchondral bone degradation | ↑ MMP-13, COL Ⅹ in cartilage; P16ink4a, pSMAD3, CTSK in subchondral bone |
| C57BL/6NCrSlc mice ( | 80-week-old | Cartilage defection | Subchondral bone degradation | ↓ H3K9Me1, H3K9Me2, H3K9Me3 in hypertrophic layer |
| ICR mice ( | 28-week-old | Cartilage defection | Subchondral bone degradation | — |
| Dunkin-Hartley guinea pigs ( | 12-week-old | Cartilage matrix degradation | Large marrow cavities | ↑ CAD-11, MMP-3 in proliferative and hypertrophic layer of cartilage |
| Horses ( | — | Cartilage matrix degradation | Articular disc degradation | — |
List of genes of genetically modified models.
| Protein | Mice model | Changes of Condylar Cartilage | Changes in other parts of TMJ | Molecular Mechanisms |
|---|---|---|---|---|
| Genes encoding regulators of chondrocyte homeostasis | ||||
| Beta cadherin associated protein |
| Cartilage defection | Subchondral bone sclerosis | ↑ COL X in hypertrophic layer; RUNX2, |
|
| Cartilage matrix degradation | Subchondral bone sclerosis | ↑ MMP-13 in fibrous, hypertrophic layer and articular disc; COL X in cartilage; ADAMTS-4, ADAMTS-5 in fibrous layer | |
| Hypoxia-inducible transcription factor 1α |
| Cartilage matrix degradation | — | ↑ MMP-9, cleaved-CASPASE-3 in hypertrophic layer |
|
| Cartilage defection | Decreased osteogenesis and angiogenesis in subchondral bone | ↑ CASPASE-3 in cartilage; OCN in subchondral bone | |
| Osteoprotegerin |
| Cartilage matrix degradation | Subchondral bone degradation | ↑ COL X in cartilage |
| Mothers against decapentaplegic homolog 3 |
| Fibrillation | Subchondral bone degradation | ↑ MMP-9, MMP-13, CASPASE-3, CASPASE-9 in cartilage |
| Runt-related transcription factor-2 |
| Cartilage defection | — | ↓ COL X, PCNA, IHH in hypertrophic layer; |
| Osterix |
| Cartilage defection | Subchondral bone degradation | ↑ COL II, COL X, ACAN, SOX9 in hypertrophic layer |
| Bone morphogenetic protein 2 |
| Cartilage matrix degradation | Decreased mineralization | ↑ AMADTS-4, MMP-13 in cartilage |
| Transforming growth factor β1 |
| Cartilage defection | Subchondral bone degradation | ↑ VEGF, MMP-9, MMP-13, CASPASE-3 in hypertrophic |
| Axis inhibition protein 1 |
| Cartilage defection | Subchondral bone sclerosis | ↑ MMP-13, ADAMTS-5 in superficial layer; CATNB, |
| Short stature homeobox 2 |
| Cartilage dysplasia | Glenoid fossa dysplasia | ↑ MMP-9, MMP-13 in cartilage |
|
| — | Chondrocyte apoptosis in articular disc | ↑ MMP-9, MMP-13 in articular disc; COL I, MMP-9, MMP-13 in condyle | |
| 1α-hydroxylase |
| Cartilage defection | Subchondral bone degradation | ↑ 8-OHDG, γH2AX, β-GAL, p16INK4A, |
| DNA (cytosine 5)-methyltransferase 3 beta |
| Cartilage defection | — | ↑ KI67, COL X, CATNB in cartilage |
| Fibroblast growth factor receptor 3 |
| Cartilage defection | Subchondral bone resorption | ↓ |
|
| Cartilage defection | Subchondral bone sclerosis | ↑ COL X, MMP-13, ADAMTS-5 in fibrous layer; IHH, RUNX2 in cartilage | |
| Bone morphogenetic protein receptor-1A |
| Cartilage disappear and then appear | Subchondral bone sclerosis | ↓ COL II, COL X, SOX9, in cartilage; OSX in subchondral bone |
| Discoidin domain receptor 1 |
| Cartilage defection | Subchondral bone degradation | ↑ COL I, COL IX, |
| Discoidin domain receptor 2 |
| Cartilage defection | Subchondral bone degradation | — |
| Genes encoding inflammation mediators | ||||
| Interleukin-1β |
| Cartilage defection | Presence of pain | ↑ COL II, MMP-9, IL-6, COX-2, TGF-β in hypertrophic layer; NGF, TRKAR in cartilage |
|
| Cartilage matrix in fibrous layer first increase and then decrease | Subchondral bone degradation | — | |
| A disintegrin and metalloproteinase with thrombospondin motifs 5 |
| Cartilage matrix degradation | Subchondral bone degradation | ↑ ACAN in cartilage |
| Genes encoding components of the extracellular matrix | ||||
| Type II collagen |
| Cartilage defection | Diffuse osteochondral junction | ↑ TGF-β1, p-SMAD2, HTRA1 in chondrocytes; MMP-13, DDR2 in cartilage |
| Del1 mice ( | Cartilage defection | Subchondral cysts | — | |
| Type IX collagen |
| Cartilage defection | — | ↑ HTRA1, MMP-13 in fibrous layer; DDR2 in cartilage; MMP-derived type II collagen fragments in fibrous layer |
| Type XI collagen |
| Cartilage defection | — | ↑ HTRA1 in fibrous layer; DDR2, MMP-13 in cartilage; TGF-β1, p-SMAD2, HTRA1 in chondrocytes; MMP-derived type II collagen fragments in superficial layer |
| Proteoglycan-4 |
| Cartilage defection | Subchondral bone resorption | ↑ COL II, COL X in hypertrophic layer; CTSK in subchondral bone; SOX-9 in cartilage; HAS-2 in cartilage, glenoid fossa, and synovial membrane |
| Biglycan Fibromodulin |
| Cartilage defection | Articular disc disruption | ↑ COL I, COL II in fibrous layer |
| Dentin matrix protein 1 | S89G-DMP1 mice ( | Cartilage defection | Subchondral bone degradation | ↑ MMP-13, CASPASE-9 in cartilage |